4//SEC Filing
McKew John C. 4
Accession 0001126234-24-000120
CIK 0001126234other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 9:32 PM ET
Size
21.8 KB
Accession
0001126234-24-000120
Insider Transaction Report
Form 4
LUMOS PHARMA, INC.(LUMO)
McKew John C.
Chief Scientific Officer
Transactions
- Disposition to Issuer
Common Stock
2024-12-12−13,153→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−16,000→ 0 totalExercise: $2.84Exp: 2034-03-31→ Common Stock (16,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−6,541→ 0 totalExercise: $2.45Exp: 2028-08-29→ Common Stock (6,541 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−9,583→ 0 totalExercise: $2.45Exp: 2028-01-18→ Common Stock (9,583 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−14,000→ 0 totalExercise: $10.02Exp: 2032-01-31→ Common Stock (14,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−16,000→ 0 totalExercise: $3.52→ Common Stock (16,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−81,690→ 0 totalExercise: $4.82Exp: 2026-07-11→ Common Stock (81,690 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−65,000→ 0 totalExercise: $7.87Exp: 2030-03-31→ Common Stock (65,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−33,175→ 0 totalExercise: $17.35Exp: 2031-01-31→ Common Stock (33,175 underlying)
Footnotes (3)
- [F1]Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC ("DPV") (the "Merger Agreement") in exchange for (i) $4.25 in cash per share (the "Cash Amount"), plus (ii) one non-transferable contingent value right ("CVR") per share. Each restricted stock unit ("RSU") was cancelled and will receive the Cash Amount plus one CVR per RSU.
- [F2]This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option.
- [F3]Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.
Documents
Issuer
LUMOS PHARMA, INC.
CIK 0001126234
Entity typeother
Related Parties
1- filerCIK 0001640560
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 9:32 PM ET
- Size
- 21.8 KB